Pfizer-COVID-19 Vaccine

ApprovedVaccine

Moderna

Pfizer-COVID-19 Vaccine is one of 48 biologic programs targeting Lymphoma. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

LymphomaRecruiting

COVID-19Active, not recruiting

LymphomaApproved

Recruiting

COVID-19Preclinical

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Pfizer-COVID-19 Vaccine

Moderna

Approved

1 2

Aldactone

Pfizer

Preclinical

1 3

Nexavar

Bayer

Preclinical

1 4

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 5

Benadryl

PParkedale

Preclinical

1 6

Rayaldee

OOrganon and Co

Preclinical

1 7

SARS-COV-2 VACCINE

Moderna

Preclinical

2 8

Statins

Sanofi

Preclinical

1 9

Olokizumab

UCB

Preclinical

1 10

Vit D

PPost Graduate Institute of Medical Education and Research, Chandigarh

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

ApprovedRecruiting

Lymphoma

NCT05170399

Clinical

Trials by Indication[1]

COVID-191 trial

An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

Completed· Moderna logo

Moderna··NCT05765578·1,713 enrolled

Lymphoma1 trial

Vaccine Responses in Patients With B Cell Malignancies

Recruiting·NNational Heart, Lung, and Blood Institute (NHLBI)·Approved·NCT05170399·350 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Pfizer-COVID-19 Vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pfizer-COVID-19 Vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pfizer-COVID-19 Vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Moderna company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: Moderna

Pfizer-COVID-19 Vaccine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Trials by Indication[1]

COVID-191 trial

Lymphoma1 trial

References

Drug Info

Quick Facts

Related News